{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:21Z","timestamp":1791186981826,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0040164","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T21:00:16Z","timestamp":1341608416000},"page":"e40164","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":132,"title":["FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Murielle M.","family":"V\u00e9niant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Helmering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanaka","family":"Stanislaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Busby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vonderfecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator.","volume":"115","author":"A Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"981315","DOI":"10.1155\/2011\/981315","article-title":"FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology.","volume":"2011","author":"Y Murata","year":"2011","journal-title":"J Nutr Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver.","volume":"1492","author":"T Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.","volume":"5","author":"MK Badman","year":"2007","journal-title":"Cell Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.","volume":"5","author":"T Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.","volume":"58","author":"J Xu","year":"2009","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.","volume":"148","author":"A Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1210\/en.2009-0119","article-title":"Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.","volume":"150","author":"Y Hotta","year":"2009","journal-title":"Endocrinology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.","volume":"150","author":"MK Badman","year":"2009","journal-title":"Endocrinology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.21357","article-title":"FGF-21\/FGF-21 receptor interaction and activation is determined by betaKlotho.","volume":"215","author":"A Kharitonenkov","year":"2008","journal-title":"J Cell Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2011.03.003","article-title":"The FGFR D3 Domain Determines Receptor Selectivity For Fibroblast Growth Factor 21.","volume":"408","author":"J Gupte","year":"2011","journal-title":"J Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2007-0313","article-title":"betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.","volume":"22","author":"M Suzuki","year":"2008","journal-title":"Mol Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.","volume":"282","author":"H Kurosu","year":"2007","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21.","volume":"104","author":"Y Ogawa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models\u2013Association with liver and adipose tissue effects.","volume":"297","author":"J Xu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","article-title":"Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.","volume":"8","author":"T Inagaki","year":"2008","journal-title":"Cell Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1210\/jc.2008-2331","article-title":"Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.","volume":"94","author":"H Li","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.","volume":"12","author":"I Shimomura","year":"1998","journal-title":"Genes Dev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice.","volume":"269","author":"MA Pelleymounter","year":"1995","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1074\/jbc.M207665200","article-title":"Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance.","volume":"278","author":"C Colombo","year":"2003","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.","volume":"401","author":"I Shimomura","year":"1999","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0905310107","article-title":"Inflammation and adipose tissue macrophages in lipodystrophic mice.","volume":"107","author":"L Herrero","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones.","volume":"148","author":"PA Dutchak","year":"2012","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/en.2010-1262","article-title":"Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.","volume":"153","author":"C Hale","year":"2012","journal-title":"Endocrinology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI11245","article-title":"Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.","volume":"106","author":"L Chao","year":"2000","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/MCB.18.7.3966","article-title":"Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation.","volume":"18","author":"YR Hadari","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14728222.10.1.135","article-title":"Shp2 as a therapeutic target for leptin resistance and obesity.","volume":"10","author":"GS Feng","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.","volume":"59","author":"FM Fisher","year":"2010","journal-title":"Diabetes"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0040164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:19:32Z","timestamp":1540336772000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0040164"}},"subtitle":[],"editor":[{"given":"Britta","family":"Siegmund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0040164","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]}}}